These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30213806)

  • 1. CT versus MR Imaging in Estimating Cochlear Radiation Dose during Gamma Knife Surgery for Vestibular Schwannomas.
    Faramand AM; Kano H; Johnson S; Niranjan A; Flickinger JC; Lunsford LD
    AJNR Am J Neuroradiol; 2018 Oct; 39(10):1907-1911. PubMed ID: 30213806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma knife radiosurgery for vestibular schwannoma: early hearing outcomes and evaluation of the cochlear dose.
    Lasak JM; Klish D; Kryzer TC; Hearn C; Gorecki JP; Rine GP
    Otol Neurotol; 2008 Dec; 29(8):1179-86. PubMed ID: 18931646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma knife radiosurgery for vestibular schwannomas: results of hearing preservation in relation to the cochlear radiation dose.
    Timmer FC; Hanssens PE; van Haren AE; Mulder JJ; Cremers CW; Beynon AJ; van Overbeeke JJ; Graamans K
    Laryngoscope; 2009 Jun; 119(6):1076-81. PubMed ID: 19399836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric Analysis of Neural and Vascular Structures in Skull Base Tumors Treated with Stereotactic Radiosurgery.
    Haidar YM; Bhatt JM; Ghavami Y; Moshtaghi O; Schwer A; Chenery S; Djalilian HR
    Otolaryngol Head Neck Surg; 2017 May; 156(5):857-862. PubMed ID: 28195750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosurgery of vestibular schwannoma: prognostic factors for hearing outcome using 3D-constructive interference in steady state (3D-CISS).
    Wagner F; Gandalini M; Hakim A; Ermis E; Leiser D; Zbinden M; Anschuetz L; Raabe A; Caversaccio M; Wiest R; Herrmann E
    Strahlenther Onkol; 2018 Dec; 194(12):1132-1143. PubMed ID: 30203112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inherent functional dependence among cochlear dose surrogates for stereotactic radiosurgery of vestibular schwannomas.
    Ma L; Braunstein SE; Theodosopoulos PV; McDermott MW; Sneed PK
    Pract Radiat Oncol; 2017; 7(1):e1-e7. PubMed ID: 27742557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic radiosurgery for vestibular schwannomas: average 10-year follow-up results focusing on long-term hearing preservation.
    Watanabe S; Yamamoto M; Kawabe T; Koiso T; Yamamoto T; Matsumura A; Kasuya H
    J Neurosurg; 2016 Dec; 125(Suppl 1):64-72. PubMed ID: 27903183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2.
    Sun S; Liu A
    J Neurosurg; 2014 Dec; 121 Suppl():143-9. PubMed ID: 25434947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hearing preservation in patients with vestibular schwannoma treated with Gamma Knife surgery.
    Baschnagel AM; Chen PY; Bojrab D; Pieper D; Kartush J; Didyuk O; Naumann IC; Maitz A; Grills IS
    J Neurosurg; 2013 Mar; 118(3):571-8. PubMed ID: 23216466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric comparison of Linac-based (BrainLAB®) and robotic radiosurgery (CyberKnife ®) stereotactic system plans for acoustic schwannoma.
    Dutta D; Balaji Subramanian S; Murli V; Sudahar H; Gopalakrishna Kurup PG; Potharaju M
    J Neurooncol; 2012 Feb; 106(3):637-42. PubMed ID: 21892741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cochlea radiation dose correlates with hearing loss after stereotactic radiosurgery of vestibular schwannoma.
    Hayden Gephart MG; Hansasuta A; Balise RR; Choi C; Sakamoto GT; Venteicher AS; Soltys SG; Gibbs IC; Harsh GR; Adler JR; Chang SD
    World Neurosurg; 2013; 80(3-4):359-63. PubMed ID: 22484770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.
    Patel KS; Ng E; Kaur T; Miao T; Kaprealian T; Lee P; Pouratian N; Selch MT; De Salles AAF; Gopen Q; Tenn S; Yang I
    J Neurooncol; 2019 Nov; 145(2):329-337. PubMed ID: 31552587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of cochlear dose in the radiosurgical treatment of vestibular schwannoma: controversies and unanswered questions.
    Jacob JT; Carlson ML; Schiefer TK; Pollock BE; Driscoll CL; Link MJ
    Neurosurgery; 2014 May; 74(5):466-74; discussion 474. PubMed ID: 24476904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma Knife radiosurgery for intravestibular and intracochlear schwannomas.
    Tuleasca C; George M; Schiappacasse L; Patin D; Fenu J; Maire R; Levivier M
    Acta Neurochir (Wien); 2019 Jan; 161(1):63-67. PubMed ID: 30535852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with hearing preservation after Gamma Knife surgery for vestibular schwannomas in patients who retain serviceable hearing.
    Hasegawa T; Kida Y; Kato T; Iizuka H; Yamamoto T
    J Neurosurg; 2011 Dec; 115(6):1078-86. PubMed ID: 21961962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of subpixel magnetic resonance imaging shifts on radiosurgical dosimetry for vestibular schwannoma.
    Borden JA; Tsai JS; Mahajan A
    J Neurosurg; 2002 Dec; 97(5 Suppl):445-9. PubMed ID: 12507073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irradiation of cochlear structures during vestibular schwannoma radiosurgery and associated hearing outcome.
    Massager N; Nissim O; Delbrouck C; Delpierre I; Devriendt D; Desmedt F; Wikler D; Brotchi J; Levivier M
    J Neurosurg; 2007 Oct; 107(4):733-9. PubMed ID: 17937216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic radiosurgery versus stereotactic radiotherapy for patients with vestibular schwannoma: a Leksell Gamma Knife Society 2000 debate.
    Linskey ME
    J Neurosurg; 2000 Dec; 93 Suppl 3():90-5. PubMed ID: 11143270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of hearing loss after gamma knife radiosurgery for vestibular schwannomas: age, cochlear dose, and tumor coverage.
    Brown M; Ruckenstein M; Bigelow D; Judy K; Wilson V; Alonso-Basanta M; Lee JY
    Neurosurgery; 2011 Sep; 69(3):605-13; discussion 613-4. PubMed ID: 21471832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hearing preservation following fractionated stereotactic radiotherapy for vestibular schwannomas: prognostic implications of cochlear dose.
    Thomas C; Di Maio S; Ma R; Vollans E; Chu C; Clark B; Lee R; McKenzie M; Martin M; Toyota B
    J Neurosurg; 2007 Nov; 107(5):917-26. PubMed ID: 17977261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.